医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

眼科医療

Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase 2/3 Clinical Trial of HBM9161 in Graves’ Ophthalmopathy

Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase 2/3 Clinical Trial of HBM9161 in Graves’ Ophthalmopathy

バイオテクノロジーヘルスケア眼科医療臨床試験製薬　 TimeLine: Clinical Trial of HBM9161 Graves’ Ophthalmopathy Harbour BioMed Receives Chinese Regulatory Approval of IND Application to Begin Seamless Phase

2020年06月02日

Samsung Bioepis Announces 24-week Interim Results from a Phase 3 Trial of SB11, Proposed Ranibizumab Biosimilar

Samsung Bioepis Announces 24-week Interim Results from a Phase 3 Trial of SB11, Proposed Ranibizumab Biosimilar

バイオテクノロジーヘルスケア眼科医療臨床試験製薬　 TimeLine: from a Phase Proposed Ranibizumab Biosimilar Samsung Bioepis Announces Trial of SB11 week Interim Results

2020年05月18日

Arctic Vision Announces Formation of Scientific Advisory Board

Arctic Vision Announces Formation of Scientific Advisory Board

バイオテクノロジーヘルスケア眼科医療臨床試験　 TimeLine: Arctic Vision Announces Formation of Scientific Advisory Board

2020年05月15日

Topcon Singapore Medical Announces its New Managing Director

Topcon Singapore Medical Announces its New Managing Director

ヘルスケア医療機器医療用品眼科医療　 TimeLine: Topcon Singapore Medical Announces its New Managing Director

2020年04月23日

Smart Eye Camera Got Listed in the Valued Supplier List of IAPB for the First Time as a Medical Device from Japanese Corporate

Smart Eye Camera Got Listed in the Valued Supplier List of IAPB for the First Time as a Medical Device from Japanese Corporate

ヘルスケア医療機器眼科医療　 TimeLine: from Japanese Corporate Smart Eye Camera Got Listed in the Valued Supplier List of IAPB for the First Time as a Medical Device

2020年04月07日

Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases

Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases

バイオテクノロジーヘルスケア幹細胞眼科医療製薬　 TimeLine: Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research

2020年04月01日

Senshinkai Eye Clinics Started “Kobe Kanagawa Support Program” for the Patients Formerly Treated by Kobe Kanagawa Eye Clinics

Senshinkai Eye Clinics Started “Kobe Kanagawa Support Program” for the Patients Formerly Treated by Kobe Kanagawa Eye Clinics

ヘルスケア眼科医療　 TimeLine: for the Patients Formerly Treated by Kobe Kanagawa Eye Clinics Kobe Kanagawa Support Program Senshinkai Eye Clinics Started

2020年03月12日

医療法人先進会先進会眼科が、旧神戸神奈川アイクリニックの保証患者様向けに「神戸神奈川サポートプログラム」を開始

医療法人先進会先進会眼科が、旧神戸神奈川アイクリニックの保証患者様向けに「神戸神奈川サポートプログラム」を開始

ヘルスケア眼科医療　 TimeLine: 保証患者様向け先進会眼科医療法人先進会旧神戸神奈川アイクリニック神戸神奈川サポートプログラム

2020年03月12日

TÜV Rheinland Launches Eyesafe Display Standard, New Requirements Guide Industry to Improve Users’ Eye Health

TÜV Rheinland Launches Eyesafe Display Standard, New Requirements Guide Industry to Improve Users’ Eye Health

バイオテクノロジーヘルスケア眼科医療　 TimeLine: Eye Health New Requirements Guide Industry to Improve Users Rheinland Launches Eyesafe Display Standard TÜV

2020年03月07日